News and Press Releases
Biointelect and CR2O Forge New Strategic Partnership to Provide Advanced End-To-End Commercialisation Solutions for The Life Sciences Sector Globally
Driving more efficient and accelerated results from pre-clinical trials to commercialisation of new therapies for Australian, European and US firms 15 February 2024 -- Maarssen, The Netherlands, and Sydney, Australia...
Category: Other
Posted: February 15, 2024
Real-World Evidence Demonstrates Feasibility and Safety of Outpatient Administration of Yescarta (axicabtagene ciloleucel)
Findings show comparable safety for patients administered axicabtagene ciloleucel in the outpatient setting in the US to inpatient infusion Real-world evidence supports further exploration of use of outpatient administration of...
Category: Clinical Trials
Posted: February 15, 2024
Optibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams...
Category: Biotechnology, Drug Discovery
Posted: February 15, 2024
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK
NICE has issued guidance for GSK’s Omjjara (momelotinib) as a treatment option for disease-related splenomegaly or symptoms in adult myelofibrosis patients with moderate to severe anaemia
Myelofibrosis is a rare blood cancer that can result in the progressive scarring of bone marrow (fibrosis), impairing its normal function There are approximately 1,970 people living with myelofibrosis across...
Category: Clinical Trials
Posted: February 15, 2024
Northway Biotech’s BIO CITY in Vilnius: significant progress in gene therapy centre development
15 January 2024 – Vilnius, Lithuania – In Vilnius, Lithuania, a pivotal moment was marked with the first topping-out ceremony at the BIO CITY complex, a project developed by the...
Category: BioManufacturing, Drug Discovery
Posted: February 15, 2024
Freudenberg Medical Establishes Second Production Facility in Costa Rica
$25m investment to meet growing global demand for medical devices and precision components Expansion to quadruple manufacturing footprint for high volume minimally invasive catheters Creation of 600 new jobs, fostering...
Category: Manufacturing and Packing
Posted: February 15, 2024
Gilead Sciences Strengthens Commitment to Inflammatory Disease with New Research Centre
14 February 2024 -- Oxford, UK -- On 14 February, Gilead Sciences held a ribbon-cutting event to celebrate the opening of its new research site at the Business Park in...
Category: BioManufacturing
Posted: February 14, 2024
ELRIG UK ANNOUNCES STEVE BATES AND DR ANDERSON RYAN AS KEYNOTE SPEAKERS AT RESEARCH AND INNOVATION 2024
ELRIG Research and Innovation 2024 takes place from 20–21 March in Manchester, UK Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal-free drug discovery Launch of TechBio Breakthrough...
Category: Biotechnology, Drug Discovery
Posted: February 14, 2024
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing
PPD clinical research business provides lab customers a comprehensive solution to help ensure safe medicines for patients 13 February 2024 -- North Carolina, US -- The PPD clinical research business...
Category: Biotechnology
Posted: February 14, 2024
BIO-Europe Spring 2024 returns to Barcelona
13 February 2024 – Munich, Germany – The eighteenth annual BIO-Europe Spring, the premier springtime partnering conference, will take place 18-20 March 2024 in Barcelona, Spain. After remarkable attendance in...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: February 13, 2024
CCIB Barcelona Plaça de Willy Brandt 11-14 08019 Barcelona Spain
Germany’s Bioscientia launches clinical PacBio HiFi WGS Test to diagnose sensory disorders
8 February 2024 – New York, NY, US – The human genetics division of German laboratory diagnostics company Bioscientia has launched a clinical long-read whole-genome sequencing test to diagnose patients...
Category: Biotechnology, Drug Discovery
Posted: February 12, 2024
Aston University and University of Warwick team wins £1.8m for research to aid drug discovery and sustainable chemical production
The team will engineer cells to make membrane proteins efficiently The proteins will be used for drug discovery and screening, and as catalysts in sustainable chemical production The £1.8m Engineering...
Category: Drug Discovery
Posted: February 12, 2024
International hologram trade body targets China expansion with new agreement
12 February 2024 – The global hologram trade body is stepping up its presence in China in a move to boost growth and promote the technology’s benefits to brand owners,...
Category: Logistics, Manufacturing and Packing
Posted: February 12, 2024
2.4 The Beacon, Beaufront Park, Anick Road Hexham, Northumberland, NE46 4TU, UK
Germany’s Bioscientia Launches Clinical PacBio HiFi WGS Test to Diagnose Sensory Disorders
8 February 2024 -- New York, US -- The human genetics division of German laboratory diagnostics company Bioscientia has launched a clinical long-read whole-genome sequencing test to diagnose patients with...
Category: Drug Discovery
Posted: February 9, 2024
Janssen Submits Type II Extension of Indication Application to the European Medicines Agency Seeking Approval of RYBREVANT (amivantamab), in combination with Lazertinib, for the First-Line Treatment of Patients with EGFR Mutated Non-Small Cell Lung Cancer
The submission is supported by data from the Phase 3 MARIPOSA study, showing statistically significant and clinically meaningful improvement in progression-free survival in patients with EGFR-mutated advanced NSCLC treated with...
Category: Drug Discovery
Posted: February 8, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
